Zealand Pharma A/S Q2 2022 Earnings Call Transcript - Thomson StreetEvents

Zealand Pharma A/S Q2 2022 Earnings Call Transcript

Zealand Pharma A/S Q2 2022 Earnings Call Transcript - Thomson StreetEvents
Zealand Pharma A/S Q2 2022 Earnings Call Transcript
Published Aug 11, 2022
11 pages (6295 words) — Published Aug 11, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ZELA.CO earnings conference call or presentation 11-Aug-22 2:00pm GMT

  
Brief Excerpt:

...Thank you, Anna, and thanks to everyone for joining today. Please turn to Slide 3. This has been a busy quarter for the company, and I'm really happy with the progress we have made on multiple fronts following the announcement of our strategy to prioritize investments into R&D. In light of these changes, I'm pleased that we completed the sales of V-Go to MannKind in May. For the Zegalogue rescue pen, we are in advanced partner discussions, and I hope to provide an update on this front soon....

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Zealand Pharma A/S
Ticker
ZELA.CO
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Thomas Schultz Bowers - Danske Bank A/S, Research Division - Analyst : Yes. A couple of questions from my side here. So can you maybe just give us a little bit of color on the US delisting. So in terms of annual cost savings, so including fees and insurance and legal stuff? So that was the first question. So just -- then just a follow-up on Zegalogue, can you maybe just remind us on the commercial commitments you have here now going into August? So is there anything that makes things a little bit more difficult for you? And also in addition to that, the recent (technical difficulty) infusion. So I'm just wondering whether you are maybe looking more into sort of an out-license with royalties compared to sort of a one-time upfront payment from just selling the asset? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 11, 2022 / 2:00PM, ZELA.CO - Q2 2022 Zealand Pharma A/S Earnings Call And then my last question, just on BI 45. Just wondering in regards to -- of course, we are all awaiting the Phase II, but I mean Boehringer, private company, they could also make a decision prior to those Phase II data and then go into -- or announce Phase III. So I'm just wondering if whether you have any information, or maybe even could potentially see Boehringer take that decision prior to the Phase II data, if that's possible?

Table Of Contents

Zealand Pharma A/S Annual Shareholders Meeting Transcript – 2023-03-29 – US$ 54.00 – Edited Transcript of ZELA.CO shareholder or annual meeting 29-Mar-23 1:00pm GMT

Zealand Pharma A/S Q4 2022 Earnings Call Transcript – 2023-03-02 – US$ 54.00 – Edited Transcript of ZELA.CO earnings conference call or presentation 2-Mar-23 1:00pm GMT

Zealand Pharma A/S Q3 2022 Earnings Call Transcript – 2022-11-10 – US$ 54.00 – Edited Transcript of ZELA.CO earnings conference call or presentation 10-Nov-22 3:00pm GMT

Zealand Pharma A/S Corporate Call Transcript – 2022-09-30 – US$ 54.00 – Edited Transcript of ZELA.CO conference call or presentation 30-Sep-22 12:00pm GMT

Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-14 – US$ 54.00 – Edited Transcript of ZELA.CO presentation 14-Sep-22 4:20pm GMT

Zealand Pharma A/S Q1 2022 Earnings Call Transcript – 2022-05-12 – US$ 54.00 – Edited Transcript of ZELA.CO earnings conference call or presentation 12-May-22 2:00pm GMT

Zealand Pharma A/S at Needham Healthcare Conference (Virtual) Transcript – 2022-04-11 – US$ 54.00 – Edited Transcript of ZELA.CO presentation 11-Apr-22 1:30pm GMT

Zealand Pharma A/S Corporate Update Call Transcript – 2022-03-30 – US$ 54.00 – Edited Transcript of ZELA.CO conference call or presentation 30-Mar-22 2:30pm GMT

Zealand Pharma A/S Q4 2021 Earnings Call Transcript – 2022-03-10 – US$ 54.00 – Edited Transcript of ZELA.CO earnings conference call or presentation 10-Mar-22 3:00pm GMT

Zealand Pharma A/S Q3 2021 Earnings Call Transcript – 2021-11-11 – US$ 54.00 – Edited Transcript of ZELA.CO earnings conference call or presentation 11-Nov-21 3:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Zealand Pharma A/S Q2 2022 Earnings Call Transcript" Aug 11, 2022. Alacra Store. May 03, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2022-Zealand-Pharma-A-S-Earnings-Call-T15288036>
  
APA:
Thomson StreetEvents. (2022). Zealand Pharma A/S Q2 2022 Earnings Call Transcript Aug 11, 2022. New York, NY: Alacra Store. Retrieved May 03, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2022-Zealand-Pharma-A-S-Earnings-Call-T15288036>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.